Dt&CRO

Dt&CRO is a South Korean full-service Contract Research Organization (CRO) that provides comprehensive research services ranging from non-clinical GLP toxicity, PK, and efficacy tests to bioequivalence testing and clinical trials. The company supports the development of pharmaceuticals, chemicals, functional foods, cosmetics, and medical devices, with a strong focus on facilitating FDA IND/NDA processes for its clients. Founded in 2017, the company has established itself as a key player in the Korean biotech ecosystem, notably becoming the first organization in Korea to develop an in-house SEND (Standard for Exchange of Nonclinical Data) program. Dt&CRO operates multiple specialized research centers, including Safety Evaluation, Efficacy Evaluation, and Bioanalysis centers, and maintains strategic partnerships, such as its collaboration with Radyus Research for US FDA consulting.